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MicroRNAs (miRNAs) are known to play diverse roles in the regulation of vertebrate development. To
investigate miRNA-target mRNA relationships in embryonic development, we have carried out small-
RNA sequencing to identify miRNAs expressed in the early gastrula of Xenopus laevis. We identify a total
of 180 miRNAs, and we have identiﬁed the locations of the miRNA precursor sequences in the X. laevis
genome. Of these miRNAs, 141 represent miRs previously identiﬁed in Xenopus tropicalis. Alignment to
human miRNAs led to the identiﬁcation of 39 miRNAs that have not previously been described for Xe-
nopus. We have also used a biochemical approach to isolate mRNAs that are associated with the RNA-
Induced Silencing Complex (RISC) in early gastrulae and thus candidate targets of miRNA-dependent
regulation. Interrogation of this RISC-associated mRNA pool by RT-PCR indicates that a number of genes
essential for early patterning and speciﬁcation may be under regulation by miRNAs. Smad1 transcripts
are associated with the RISC; target prediction algorithms identify a single miRNA-binding site for miR-
26, which is common to the 3′UTRs of Smad1a and Smad1b. Disruption of the interaction between miR-
26 and the Smad1 3′UTR via a Target Protector Morpholino Oligonucleotide (TPMO) leads to a 2-fold
increase in Smad1 protein accumulation, moderate increases in the expression of BMP4/Smad1 target
genes, and a reduction in organizer gene expression, as well as a partially ventralized phenotype in
approximately 25% of embryos. Overexpression of miR-26 resulted in moderately decreased expression
of Smad1-dependent genes and an expansion of the region expressing the Organizer gene not1. Our
ﬁndings indicate that interactions between miR-26 and the Smad1 3′UTR modulate Smad1 function in
the establishment of axial patterning; they also establish a foundation for the functional analysis of
miRNAs and their regulatory interactions during gastrulation.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Vertebrate development is governed by transcriptional reg-
ulatory networks that mediate the speciﬁcation of germ layers, the
establishment of dorsal-ventral and anteroposterior pattern, and
the establishment and differentiation of distinct lineages. These
networks are modulated, however, by post-transcriptional me-
chanisms, including the regulation of translation or RNA localiza-
tion by RNA-binding proteins, microRNA-dependent translational
control, and nonsense-mediated decay. In particular, microRNAsdescribed in this manuscript.
Medicine, University of Cali-(miRNAs) have been shown to play important roles in a range of
vertebrate developmental processes, such as neural development
(e.g., Giraldez et al., 2005; Bonev et al., 2011), morphogenesis
(Goto et al., 2010), and the transition from maternal to zygotic
control (reviewed in Giraldez (2010)). While many speciﬁc in-
stances of miRNA-dependent regulation have been described, a
global assessment of miRNA functions in vertebrate development
in vivo has yet to be elucidated.
MicroRNAs offer several speciﬁc challenges to the elucidation
of their roles in developmental processes. A given miRNA may
interact with dozens of transcripts present in the cell type of in-
terest. Moreover, transcripts vary signiﬁcantly in the number of
miRNAs that may bind to their 3′UTRs, and for a transcript with
many predicted miRNA binding sites, the functional signiﬁcance of
any one miRNA may be negligible. The computational methods
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sequence are of limited accuracy. Moreover, estimates suggest that
30–60% of mammalian transcripts are regulated by miRNAs (e.g.,
Friedman et al., 2009). A thorough assessment of miRNA functions
in developmental processes will require the identiﬁcation of
transcripts regulated by miRNAs.
In this paper, we use high-throughput sequencing to identify
miRNAs expressed at the early gastrula stage in Xenopus laevis, and
compare our ﬁndings to those of a similar study in Xenopus tro-
picalis. We also use co-immunoprecipitation of Argonaute Ribo-
nucleoprotein (RNP) complexes to isolate mRNAs that are candi-
date targets of miRNA-dependent regulation, and show that many
key regulatory components may be targets of miRNA-mediated
translational control. Finally we demonstrate that one target
identiﬁed via Argonaute-RNP co-immunoprecipitation, Smad1, is
regulated by miR-26, and that this regulatory interaction is im-
portant for dorsal–ventral pattern and regionalization of the
anterior neural ectoderm.2. Methods
2.1. Small RNA library preparation and sequencing
For the ﬁrst round, 10 mg of RNA was isolated from each of
3 independent sets of st. 10.25 Xenopus embryos and fractionated
on acrylamide–urea gels in order to collect the 18–30 nucleotide
fraction. This small RNA pool was then ligated to modiﬁed oligo-
nucleotide adapters, reverse transcribed, and ampliﬁed using the
Illumina Small RNA DGE kit. The second round of samples was
prepared from 3 additional sets of embryos using the NEBNext
Small RNA Library Prep kit. Samples were sequenced on an Illu-
mina Genome Analyzer II (University of Houston Institute for
Molecular Design Sequencing Center; UH-IMDSC).
2.2. Identiﬁcation of miRNAs
The sequencing output was analyzed by two independent
methods to establish conﬁrmation of identiﬁed miRNAs. Cutadapt
(Martin, 2011) was used to trim the raw sequences, and the
trimmed reads were subjected to a bioinformatic pipeline devel-
oped by P.H.G. and colleagues (Creighton et al., 2009) where they
aligned to X. tropicalis and human miRNA datasets from miRbase
19.0 (Kozomara and Grifﬁths-Jones, 2011). In this case, miRNAS
were identiﬁed by homology to X. tropicalis or human miRNAs
withr4 mismatches.
In the second approach developed by our lab, we obtained
reference index ﬁles for the X. laevis genome assembly 7.1 (Nov
2012) (genome assembly available through Xenbase www.xen
base.org; James-Zorn et al., 2013) and aligned our trimmed reads
using miRDeep (Friedländer et al., 2008). The aligned reads to the
genome were re-aligned to X. tropicalis and human miRNA data-
sets from miRbase 19.0; these alignments generated the read
counts and genomic coordinates for individual miRNAs. The miR-
Deep program incorporates RNAfold (Lorenz et al., 2011) to predict
RNA secondary structures for candidate precursor miRNA se-
quences. The miRDeep program was able to identify the locations
of miRs based on the alignments with the genome assembly. There
are two or more loci for nearly all of the X. laevis miRs, as is the
case for over 75% of the protein-coding genes; the appearance of
multiple loci is a feature of the allo-tetraploid X. laevis genome
resulting from the hybridization, and subsequent retention of
functional chromosomes, of two ancestral species. Therefore, the
miRDeep program retrieved two locations for a given miR, where
mature miRNA sequences were identical. The genomic locations of
such miRs are included in Suppl. Table 3. Although the read countsfor such miRs were noted twice by the algorithm, miRs with
identical mature sequences were counted as a single miR, without
regard for genomic location.
We also used Bowtie (v. 1) (Langmead et al., 2009) to create
reference index ﬁles for the X. laevis genome assembly 7.1 (Nov
2012) and aligned our trimmed reads. The trimmed reads were
12–36 bp in length; over 70% of the reads would align to the
genome, allowing a single mismatch (bowtie options – n 1 –e 80 –l
12 –a-best-strata). These aligned reads were then realigned to X.
tropicalis and human mature miR hairpin sequences using bowtie
(v. 1), allowing 2 mismatches (bowtie options – n 2 –e 100 –l 10 –
a). The resulting SAM ﬁles showed that more than 8–10% of the
reads would align with miR hairpin sequences. The remaining
unaligned reads may represent other small RNAs, similar to those
previously identiﬁed (Harding et al., 2014; Gardner et al., 2012).
The SAM ﬁles were converted to BED ﬁles using SAMtools (Li et al.,
2009) and BEDtools (Quinlan and Hall, 2010). BEDtools was then
used to extend the genomic sequence 75 bp either upstream or
downstream of the aligned miRNA, generating separate upstream
or downstream sequences for each aligned miRNA. Each sequence
was evaluated for the presence of the predicted miRNA stem-loop
secondary structure (Ambros et al., 2003) using RNAfold (Lorenz
et al., 2011) and individual assessment of the following criteria:
(1) stable stem-loop structure; (2) minimum free
energyo15 kcal/mol; (3) strong base pairing between mature
miRNA and complementary sequence acrossZ15 nucleotides;
(4) exclusion of mature miRNA sequence from loop; (5) a loop of
46 nucleotides. Sequences meeting these criteria were considered
to be valid precursor (stem-loop) miRNA sequences. The miRNA
folding outputs from the miRDeep/RNAfold and BEDtools/RNAfold
scripts were compared to provide conﬁrmation of valid precursor-
miRNA sequences. Speciﬁc Bowtie parameters used and success
rates for alignments are provided in Suppl. Information 1.
2.3. Preparation of myc-Ago2 construct
A full-length clone of eukaryotic Translation Initiation Factor
2C,1 (eIF2C1) (Genbank Accession number BC077863; UniGene
Xl.43287) was obtained from Open Biosystems; this gene corres-
ponds to Ago2. The coding sequence was subcloned into pCS2þ-
myc to generate a N-terminal myc-tagged Ago construct (myc-
Ago).
2.4. Microinjection
Embryos were obtained and microinjected as described in Sive
et al. (2000). Capped RNAs for microinjection were prepared from
linearized plasmid templates using the mMessage mMachine kit
(Life Technologies). Morpholino oligonucleotides (Gene Tools) and
Locked Nucleic Acid (LNA) inhibitor oligonucleotides (Exiqon)
were prepared according to manufacturer's instructions. (miR-26
TP MO: GTCTGACTCCTTCAAGTACATGCAT miR-26 TP Mispair MO:
GTGTGACTGCTTGAACTACATCCAT (mispair bases underlined). miR-
26 MO: GCCTATCCTGGATTACTTGAA). Duplexed miR-26 RNA or
mispair miR-26 (“mtt-26”) (IDT) was resuspended, heated to 80°
for 1 min, and then cooled to room temperature, as described in
Walker and Harland (2009).
2.5. Co-immunoprecipitation and isolation of Ago RNP
Co-immunoprecipitation was carried out as a modiﬁcation of
methods described in Keene et al. (2006). Embryos overexpressing
myc-Ago were lysed in Keene Lysis Buffer [100 mM KCl, 5 mM Mg
Cl2, 10 mM HEPES, pH 7.0, 0.55 NP-40, 1 mM DTT, 100 units/ml
RNase OUT (Life Technologies), 400 mM Vanadyl Ribonucleoside
Complex (VRC) (New England Biolabs), protease inhibitor cocktail
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trifuged to pellet the pigment granules (500 g, 10 min, 4 °C).The
supernatants were stored at 80°. For co-immunoprecipitation,
Protein A/G dynabeads (Life Technologies) were washed 3 times in
NT2 buffer þ5% BSA [NT2 buffer: 50 mM Tris HCl pH 7.4, 150 mM
NaCl, 1 mM MgCl2, 0.05% NP-40; (Keene et al., 2006)], then in-
cubated overnight with anti-myc antibody (monoclonal 9E10
(Sigma-Aldrich). Beads were again washed 5 times in cold NT2
buffer; lysates were diluted to 1 ml and added to beads for a 4-hr
incubation at 4˚ with end-over-end rotation. Beads were washed
3 times with ice-cold NT2, then twice with High Salt Wash [HSW:
5X PBS, 0.5% NP-40, 0.1% SDS], then twice with NT2. The beads
were then treated with 30 mm Proteinase K in 100 ml NT2 at 55° for
30 min; after addition of Trizol (Life Technologies), the RNA was
isolated via standard protocols, DNAse-treated, and reverse-tran-
scribed for Q-RT-PCR analysis.
2.6. Reverse transcription and Q-RT-PCR
RNA was isolated from whole embryos using Trizol, and RNA
samples were reverse transcribed with Super Script III (Life
Technologies). Q-RT-PCR assays were carried out using SYBR Green
qPCR mix (Roche Applied Sciences), and data were analyzed using
the ΔΔCt method (Livak and Schmittgen, 2001), using ornithine
decarboxylase (ODC) as a control for normalization in assays of
both total RNA and Ago-RNP RNA. Mir-dependent regulation of
ODC has previously been demonstrated (Song et al., 2010), and the
gastrula miRs include miRs predicted to bind the ODC 3′UTR (e.g.,
miR-181b). Data are presented as-fold change in experimental
values (the gene of interest/ODC) relative to the control values.
Statistical signiﬁcance was determined using a paired t test.
2.7. Immunoblotting
Immunoblotting was performed as described in Liu et al.
(2012). The intensity of each band was quantiﬁed using the “area
measurement” function of Image J (Schneider et al., 2012), a Java-
based image processing program (http://rsb.info.nih.gov/ij/indeX.
html).
2.8. Luciferase assays
The luciferase reporter constructs were generated by subclon-
ing the ﬁreﬂy luciferase gene into the BamH1 and EcoR1 sites of
pCS2þ (pLuc). The Smad1 3′UTR was ampliﬁed from animal cap
cDNA and subcloned into the Xho1 and Xba1 sites of pLuc to
produce pLuc-Smad. A 4-base mutation was engineered within the
Smad1 3′UTR across the region complementary to the miR-26 seed
sequence, yielding pLuc-Smad-MUT (Genscript). Luciferase assays
were carried out using the Promega Dual-Luciferase reporter Assay
System; the Renilla luciferase construct pRL-CMV was used for
normalization.
2.9. In situ hybridization
In situ hybridization (ISH) to detect coding genes was carried
out as described in (Sive et al., 2000). Digoxigenin-labeled probes
were prepared by in vitro transcription of linearized template
plasmid DNA as described in (Sive et al., 2000). All ISH for coding
genes were carried out on embryos from at least 3 independent
experiments; numbers of embryos showing the representative
pattern are provided in the. In some cases, numbers of embryos
are limited because embryos from each experiment were used for
ISH for multiple genes; genes showing no difference in expression
are not shown. For miR-26 in situ hybridization, a digoxigenin-
labeled miR-26 LNA probe (Exiqon) was used, according to theprotocol described in (Kloosterman et al., 2006). A single probe for
the mature miR-26 sequence was used for the ISH, since the miR-
26 sequences in the X. laevis genome do not include sequence
variants (See Suppl. Table 3).3. Results
3.1. Identiﬁcation of miRNAs expressed in early gastrula embryos
Small (18–30 nt) RNA was isolated from 6 independent sets of
early gastrula (st. 10.25) embryos and sequenced using Illumina
reagents and protocols on an Illumina GAII genome analyzer. An
initial set of 3 samples prepared with the Illumina small RNA li-
brary construction kit showed limited reproducibility among the
3 samples, which prompted a second round of sequencing of
3 additional samples prepared using the NEB small library con-
struction kit. Again, reproducibility was limited, and in all cases,
only a limited fraction of sequences were found to be clearly
identiﬁable as microRNAs. Although these sequencing efforts
yielded over 25 million reads, most of the reads were not micro-
RNAs. These results are consistent with previous reports of a large
and heterogeneous pool of small RNAs in Xenopus gastrulae
(Faunes et al., 2012; Gardner et al., 2012; Harding et al., 2014). The
read statistics for these sequencing runs are presented in Suppl.
Table 1.
Sequences were aligned with miRBase miRNAs identiﬁed from
human and X. tropicalis sequences. The workﬂow for the analysis
of miRNA sequences is shown in Fig. 1A. These alignments iden-
tiﬁed 180 miRNAs expressed in early gastrulae, including 141
aligned with the X. tropicalis set, and 39, aligned with the human
dataset, that had not previously been identiﬁed in either X. laevis
or X. tropicalis. Just 12 miRNAs comprise over 80% of the total
miRNA sequences identiﬁed (Fig. 1B); these include xtr-miRs 427,
148a, 101a, 143, and let-7a, b, c, e, f, g, along with hsa-miRs 302a
and 21-5p. The individual miRNAs and read counts are listed in
Suppl. Table 2.
We compared our set of 141 xtr miRNAs to the 76 miRNAs
identiﬁed in X. tropicalis gastrulae by Faunes et al. (2012) (“Larrain
dataset”). The Larrain dataset was obtained by alignment of X.
tropicalis gastrula reads to X. tropicalis miRNAs. The overlap be-
tween our set and the Larrain dataset is considerable (Fig. 1C): 74
miRNAs were detected in both sets, while our set included 67 that
were not observed in the Larrain dataset. The reciprocal group of
miRNAs represented in the Larrain dataset but absent from ours
included only 2 miRNAs. The miRNAs represented in both our
dataset and the Larrain dataset are indicated in Suppl. Table 2.
We also compared our miR dataset to more divergent Xenopus
miRNA datasets reported by Armisen et al. (2009) and Harding
et al. (2014). The Armisen dataset identiﬁed 166 miRNAs expressed
during X. tropicalis oogenesis, as well as miRNAs expressed in skin
and liver. There is considerable overlap between this set of miRNAs
and those identiﬁed in X. laevis gastrulae: 84% of the gastrula miRs
are represented in the Armisen dataset, while 66% of the Armisen
miRNAs are detected in gastrulae. In contrast, there is substantially
less overlap with the miRNA set reported by Harding et al. (2014),
which identiﬁes 167 miRNAs from blastula, gastrula, and neurula
embryos. Over 36% of the X. laevis gastrula miRNAs are not re-
presented in the Harding dataset, and 32% of the Harding miRNAs
do not appear among our gastrula miRNAs. Many of this latter
group were identiﬁed as sequences corresponding to miRNAs from
Drosophila or Caenorhabditis elegans; all of the Harding miRNAs
identiﬁed by alignment to known xtr or xla miRNAs were also
represented in our gastrula miRNA set.
Moreover, the miRBase datasets for human and X. tropicalis
were compared with one another; comparisons of human and X.
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Fig. 1. Identiﬁcation of miRNAs expressed at the early gastrula stage. (A) Workﬂow for alignment and identiﬁcation of miRs in the X. laevis genome. (B) Distribution of miRNA
abundance. Only 12 individual miRNAs represent over 80% of the identiﬁed miRNA sequences. (C) Venn diagram comparing representation of known xtr-miRs in X. laevis
(blue; data presented here) and X. tropicalis (yellow; data from Faunes et al. (2012)). miRs in either data set that were identiﬁed by alignment to mammalian miRs are
omitted.
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that some miRNA sequences found in X. tropicalis are not identical
to the similarly named miRNAs in the human dataset.
We used miRDeep and RNAFold to determine the genomic lo-
cations of precursor sequences for each miRNA and to conﬁrm
hairpin folding for each precursor sequence. These analyses al-
lowed us to identify genomic coordinates for these conﬁrmed
miRNAs. Most of these miRNAs are represented in multiple areas
in the X. laevis genome, usually between 2 and 6 copies. The ma-
ture miRNA sequence and genomic coordinates for each miRNA
are presented in Suppl. Table 3.
3.2. Identiﬁcation of candidate miRNA targeted transcripts by
coimmunoprecipitation
A myc-tagged Argonaute construct was generated by subclon-
ing a full-length clone of EIFC2C (Open Biosystems) into pCS2þMT.
RNA encoding this N-terminal myc-tagged Ago2 (myc-Ago) was
injected into embryos at a concentration of 200 pg/embryo; higher
concentrations were associated with reduced viability. Embryo
lysates were subjected to immunoprecipitation, and the myc-Ago-
associated (“Ago-RNP”) RNA was isolated, reverse-transcribed, and
evaluated by RT-PCR. Immunoprecipitations of uninjected em-
bryos were carried out in parallel to evaluate non-speciﬁc
associations.We assayed several genes for representation in the Ago-RNP
pool; representative RT-PCR and Q-RT-PCR assays are shown in
Fig. 2. Acvr2 served as a positive control, since its regulation by
miR15 and miR-16 has previously been shown (Martello et al.,
2007). The genes tested were chosen because they were known to
have developmentally signiﬁcant functions. These assays identi-
ﬁed smad1 and several other RNAs as candidate targets of miRNAs
expressed in early gastrulae, based on their enrichment in Ago
RNP RNA as compared with RNA immunoprecipitated from unin-
jected embryos. A second step generated bioinformatic predictions
of miRNA binding sites in the 3′UTRs of these transcripts that
corresponded to miRNAs identiﬁed in our small-RNA sequencing;
examples are shown in Fig. 2C. Bioinformatic predictions were
based on the PITA algorithm (Kertesz et al., 2007) using the X.
laevis 3′UTR sequence, as well as Targetscan 6.0 (Lewis et al., 2005)
predictions for X. tropicalis, which were then evaluated by align-
ments of the X. laevis and X. tropicalis 3′UTR sequences. We also
identiﬁed transcripts which were not enriched in the Ago RNP
pool, including geminin, and NCAM; these transcripts demon-
strated that not all transcripts are retained in the Ago-RNP pool.
3.3. Conﬁrmation of smad1 as a target of miR-26
Q-RT-PCR analyses showed that smad1was strongly represented
in the Ago-RNP RNA fraction (Fig. 2). PITA and Targetscan predict a
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mRNA were lysed at st. 10.5 in preparation for immunoprecipitation of Ago-RNP
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Q-RT-PCR (B) as described. Representative experiments are shown; nZ5 experi-
ments. In (B), Q-RT-PCR for total RNA was carried out in parallel to reveal enrich-
ment of selected RNAs in the Ago-RNP pool. (L, ladder; acvr2r, Activin Receptor 2a;
MA, muscle actin; sm1, Smad1; gsc, goosecoid; sia, siamois; fgf3, Fibroblast Growth
Factor (FGF) 3; asw, ashwin; PC1, polycomb1; TAK1, TGF-β Activated Kinase 1; -RT,
acvr2 reaction lacking reverse transcriptase; eFGF, FGF4. Acvr2a has previously
been shown to be a target of miR-15/16, and it is used as a positive control.
(C) Gastrula miRs predicted to bind to transcripts represented in Ago-RNP RNA.
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transcripts (Fig. 3A), and this site is conserved across many verte-
brate genomes. PITA and Targetscan did not identify additional sites
for miRNAs detected in early gastrulae.
Since these ﬁndings suggest that Smad1 mRNAs would be
targeted by a single miRNA at the early gastrula stage, the Smad1/
miR-26 interaction was selected for further analysis, as a “proof-of-
concept” for biochemical identiﬁcation of miRNA targets. Ad-
ditionally, Smad1 plays major roles in patterning of both meso-
derm and ectoderm, and we have previously studied the effects of
incremental gain-of-function for Smad1 in early development
(e.g., Sater et al., 2003; Liu et al., 2012). Thus, we had reagents and
assays available to detect changes in gene expression that would
be expected to result from a limited increase in smad1 protein
accumulation, as would be expected from a disruption of miRNA–
mRNA interaction.
Binding of miR-26 to the smad1b 3′UTR was validated using a
luciferase “sensor” construct containing the smad1b 3′UTR (Luc-Smad1, or PLS). Embryos were injected with luc-Smad1 DNA and
either a morpholino oligonucleotide complementary to the smad1
miR-26 binding site (Smad1/miR-26 Target Protector Morpholino
Oligonucleotide, or TPMO), or a mispair MO (mis-TPMO) (Fig. 3B).
Although addition of the Smad1 3′UTR leads to a decrease in lu-
ciferase activity in comparison with pLUC alone, this decrease is
reversed by co-injection of the TPMO, suggesting that the primary
site of translational regulation on this 3′UTR lies in the region
protected by the TPMO. Luc-Smad1-dependent luciferase activity
in embryos injected with the TPMO was over 2.5-fold greater than
in embryos injected with the TP Mispair.
To conﬁrm the importance of the seed-binding region within
the smad1 3′UTR, we introduced mutations in Luc-Smad1 at 4 sites
within this region (Fig. 3C) and compared the luciferase activity of
the normal (PLS) and mutant (PLS–MUT) constructs. The relative
luciferase activity of the PLS–MUT construct is approximately
3-fold higher than the original construct (Fig. 3D). This results
demonstrates that the seed-binding region is essential for re-
sponsiveness to miR-26. We then evaluated the sensitivity of both
constructs to miR-26, along with a mispair construct (mtt-26) that
included mutations at 4 positions within the “seed” sequence
(Fig. 3C). While miR-26 inhibits activity when co-injected with
wild-type Luc-Smad1, it has a negligible effect on the activity of
the mutant Luc-Smad1 (Fig. 3E). In contrast, co-injection of miR-
26-mut with the Luc-Smad1 DNAs produces reciprocal results, in
that luciferase activity of embryos injected with the mutant Luc-
Smad1 is greatly reduced, while the wild-type Luc-Smad1 is un-
affected. These ﬁndings demonstrate the importance of the smad1
3′UTR sequence that is complementary to the miR-26 seed se-
quence, which indicates that the effects of the target protector MO
are due to the disruption of miRNA-target transcript interactions,
as opposed to other forms of translational control.
3.4. Expression of miR-26
We used an LNA probe directed against mature miR-26 to
evaluate the spatial pattern of miR-26 expression in early Xenopus
development (Fig. 4). This probe is expected to bind to primary,
precursor, and mature forms of miR-26. In situ hybridization
showed that miR-26 is strongly expressed in the dorsal and dor-
solateral areas of the midgastrula embryo, with weaker expression
in the ventral region; this dorsal–ventral difference persists in late
gastrulae. By late neurula, miR-26 is expressed in the eye and
anterior neural ectoderm. At tailbud stages, expression of miR-26
is detected most strongly in the eye, anterior neural ectoderm, and
somites.
3.5. Functional analysis of the Smad1-miR-26 interaction
To evaluate the effects of miR-26 on smad1, embryos were in-
jected with increasing amounts of the smad1 TPMO, lysed at early
gastrula, and assessed using western blots probed with anti-
Smad1 antibody. Quantiﬁcation of the blots showed that injection
of 20 ng/embryo TPMO led to a 2.5-fold increase in Smad1 protein
(Fig. 5A and B). This represented the maximal effect of the TPMO,
which was used in subsequent experiments.
Embryos were injected with 20 ng of either TPMO or TP-Mis,
lysed at early gastrula, and assayed by Q-RT-PCR to examine the
effects of the miR-26 – smad1 interaction on expression of several
smad1 transcriptional targets. Expression of the primary targets
vent2 and gata2 increased 4-6-fold, while expression of gata4 and
wnt8 increased 3-4 fold (Fig. 5D). The secondary target vent1,
however, showed a greater increase of nearly 12-fold. Since tran-
scription of vent1 is activated by vent2 and gata2 in concert, this
indicates that the effects of miR-26 are ampliﬁed from protein
accumulation through the transcription of primary and secondary
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Fig. 3. Validation of the interaction between miR-26 and the smad1 3′UTR. (A) Sequences for miR-26a, and the miR-26 binding sites within the Smad1A and Smad1B 3′UTRs.
The seed sequence in miR-26 and the corresponding seed-binding sequences in the 3′UTRs are shown in bold. The position of the miR-26 TPMO is represented by the blue
line. The pLuc-Smad1 3′UTR reporter construct (Luc-Smad1, or PLS) is also shown. For luciferase assays shown in B, D, and E, luciferase readings are normalized to those of
control samples (which are set to 1) and presented as “relative luc activity”. (B) Luciferase assay comparing activities of either luciferase alone (LUC) or the Luc-Smad1
reporter (PLS) in the presence of either the target protector (TPMO) or a 5-base mispair (mis-TPMO). Embryos were injected with the plasmids and MOs and lysed at st. 10.5.
(C) Sequences of PLS and PLS-MUT in the miR26 seed-binding region; PLS-MUT carries 4 mutations across this region. Sequences of miR-26 and the mutated miR-26 that
carries complementary mutations across the seed sequence. (D) Luciferase activity from pLuc-Smad1 3′UTR (PLS) in which 4 bases are mutated across the miR-26 seed
sequence (PLS-mut). (E) Effects of complementary mutations in the seed-binding sequence of miR-26. In the presence of miR-26, luciferase activity is higher in embryos
injected with PLS-mut than with PLS (at left). A mutated version of miR-26 (mtt-26) that is complementary to the mutations in PLS-mut signiﬁcantly inhibits luciferase
activity in embryos injected with PLS-mut (right). miRs were injected as duplexed oligoribonucleotides. For PLS, results with mtt-26 are normalized to those with mir-26; for
PLS-mut, results with miR-26 are normalized to those with mtt-26, which is complementary to PLS-mut. NZ3 independent experiments for each panel. nIndicates statistical
signiﬁcance (po0.05); nn, very signiﬁcant (po0.01); nnn, extremely signiﬁcant (po0.001).
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Additional assays examined the effects of the TPMO on orga-
nizer or neural-speciﬁc gene expression. Embryos were injected as
described and collected at mid-gastrula (st. 11) for Q-RT-PCR. Ex-
pression of the organizer-speciﬁc BMP antagonists chordin and
noggin in TPMO-injected embryos was 20–25% of levels seen in the
TP-Mis controls, while expression of NCAM and otx2 was reduced
by over half in comparison to the TP-Mis controls (Fig. 5C).
Introduction of the Smad1/miR-26 TPMO resulted in a reduc-
tion in dorso-anterior development in approximately 25% of em-
bryos (Fig. 6A–D); most of the visibly affected embryos showed a
reduction or loss of eyes, and other head defects, although dorsal
trunk development was normal. In fewer than 5% of embryos,
head formation was completely inhibited.
We evaluated the expression pattern for two Organizer genes,
otx2 and not1, in embryos injected with the TP or TP-Mis MOs
(Fig. 6 E, F, H, and I). For both genes, the arc of expression across
the Organizer region is shorter in the TPMO embryos compared
with embryos injected with the TP-Mis MO. This restriction isparticularly clear for expression of not1, which has a broader lat-
eral extent in control embryos than otx2. This restriction suggests
that the moderate increase in expression of Smad1 produced by
the TPMO leads to a narrowing of the Organizer.
We also examined the effects of the miR26 TPMO on expression
of otx2 in late neurula embryos (Fig. 6G and J). Otx2 has a complex
pattern of expression that includes large areas within the forebrain
region and a broader and less intense region ventral and lateral to
the forebrain, representing the embryonic eye ﬁeld. In embryos
injected with the miR-26 TPMO, overall expression, as well as
much of this distinct regionalization, is decreased: the eye ﬁeld
does not extend laterally, expression in lost in part of the forebrain,
and the entire extent of expression is reduced along the ante-
roposterior axis. This pattern of expression is similar to that ob-
served in embryos expressing a mutated smad1 that lacks MAPK
phosphorylation sites in the linker domain (Sater et al., 2003). The
mutations disrupting these phosphorylation sites act collectively
as a gain-of-function; thus, inhibition of the smad1/miR-26 inter-
action produces a pattern of otx2 expression that resembles that of
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Fig. 4. Expression of miR-26 during embryonic development. A, C–G, I, in situ hybridization using an LNA probe for miR-26. B, H, J, in situ hybridization using a control LNA
probe. Asterisks mark the dorsal lip of the blastopore. Images are unprocessed. (A, B) midgastrulae (st. 10.5) shown in vegetal view; dorsal (C) and ventral (D) views of late
gastrula (st. 12); anterior is at top. Lateral (E) and frontal (F) views showing expression at st. 22. (G, H) lateral view, st. 24. (I) lateral view of miR-26 expression at st. 28;
(J) control probe at st. 28. e, eye/eye ﬁeld; s, somite. Hybridizations with each probe were carried out on two independent sets of embryos.
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These experiments evaluate the effects of disrupting the
Smad1-miR-26 interaction on Smad1 activity, without disrupting
the Smad1-independent functions of miR-26. Taken together, our
results indicate that the translational control by miR-26 con-
tributes to the regulation of Smad1 protein accumulation and
smad1 function, as has been demonstrated previously in mam-
malian cells (e.g., Trompeter et al., 2013). They further demon-
strate that these interactions have functional signiﬁcance for the
modulation of BMP/Smad1-dependent transcription and the es-
tablishment of dorsal–ventral pattern.
3.5.1. miR-26 overexpression
One expected corollary of these ﬁndings is that overexpression
of miR-26 is expected to inhibit Smad1-dependent responses. To
evaluate this hypothesis, embryos were injected with duplexed
miR-26 or the mutated sequence (mtt-26) and collected at early
gastrula (st. 10.25) for either Q-RT-PCR or in situ hybridization.
Q-RT-PCR analyses showed that expression of the BMP4/Smad1
target gene vent2 was decreased in embryos injected with miR-26
RNA (Fig. 7A). While in embryos injected with the miR-26 TPMO,
the direct target vent2 was affected less strongly than the more
downstream target vent1, these effects were reversed in embryos
in which miR-26 levels were higher: here, overexpression of miR-
26 substantially inhibits vent2 expression, while the effects on the
secondary target vent1 are more limited. This difference may re-
ﬂect pleiotropic effects of miR-26 on Smad1-independent inputs tothe vent1 promoter. Expression of both of the organizer genes
chordin and not1 was moderately elevated in embryos over-
expressing miR-26, although only chordin showed a statistically
signiﬁcant increase. We also evaluated effects on three additional
genes that are not known to be responsive to either BMP/Smad1 or
miR-26: these genes, EF1-α, Ribosomal protein 18 (rps18), and
geminin, did not show statistically signiﬁcant alterations in ex-
pression, suggesting that global increases or decreases in gene
expression do not occur in response to miR-26 overexpression.
We carried out in situ analyses to evaluate the spatial pattern of
three Organizer genes in embryos overexpressing miR-26. Em-
bryos injected with miR-26 show a marked expansion of not1
expression into the dorsolateral and lateral regions of the marginal
zone relative to embryos injected with mtt-26 (Fig. 7B, and C). We
have previously shown that not1 is especially sensitive to the level
of active Smad1 in the gastrula (Liu et al., 2012). Neither otx2 nor
shh, however, showed consistent differences in expression (data
not shown).
3.5.2. miR-26 Loss-of-function
The Target Protector Morpholino Oligonucleotide studies de-
monstrate the signiﬁcance of interactions between miR-26 and the
Smad1 3′UTR in the regulation of Smad1 activity during early
development. In contrast, LNA-mediated knockdown of miR-26
should reveal the extent of miR-26 functions. Targetscan 6.2
(http://www.targetscan.org/vert_61/; Lewis et al., 2005; Friedman
et al., 2009) lists 186 genes as predicted targets of miR-26 in the X.
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Fig. 5. Increase in Smad1 following introduction of the target protector MO. (A) Representative experiment showing accumulation of Smad1 protein in the presence of
increasing amounts of TPMO. Embryos were injected with TPMO in the amounts indicated and collected at st. 10.5. (B) Quantiﬁcation of Smad1 accumulation as shown in (A).
N¼3 independent experiments. (C) Inhibition of organizer gene expression in embryos injected with 20 ng/embryo TPMO (TP-miR26 or TP mispair “Mis”). (D) Effects of the
Smad1 TPMO (20 ng/embryo) on expression of direct (vent2, gata2) and indirect (vent1) targets of Smad1. (E) Partial network of Smad1-dependent transcription. The effects
of inhibiting the interaction between the Smad1 mRNA and miR-26 are ampliﬁed at successive stages of the network. NZ3 biological replicates for Q-RT-PCR experiments. n
Indicates statistical signiﬁcance (po0.05); nn, very signiﬁcant (po0.01).
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pressed in the early gastrula embryo, based on comparisons with
the Unigene EST dataset (NCBI). Our limited comparisons have
shown that predicted miR target sites for X. laevis and X. tropicalis
orthologues are highly similar (Sater, unpub. observation). Pre-
dicted miR26 targets expressed at this stage include several
chromatin modiﬁers, such as ezh2, tet2, and baz2b, among many
other transcriptional regulators. Thus, we anticipate that miR-26
will be highly pleiotropic, and that knockdown will affect multiple
processes well beyond BMP/Smad1 signaling. As a result, the ef-
fects of miR-26 reduction- or loss-of-function may be moredifﬁcult to interpret than those of the TPMO, particularly in the
context of the whole embryo.
To carry out loss-of-function studies, we used a Locked Nucleic
Acid (LNA) oligonucleotide antagonist of miR-26 (Exiqon) to block
endogenous miR-26. Embryos were initially evaluated across a
range of concentrations; the experiments presented here used ﬁ-
nal concentrations of 2 ng/embryo; a control LNA oligonucleotide
available from Exiqon was injected in parallel to evaluate non-
speciﬁc effects. The miR-26 LNA inhibitor was evaluated via a lu-
ciferase assay using the PLS construct (Fig. 8A); at 2 ng/embryo,
the LNA inhibitor produced an increase in relative luciferase
 TP MIS
TP MO
 not1    otx2   otx2 (st 22)
Fig. 6. Phenotypic effects of blocking the interaction between Smad1 and miR-26. (A) Uninjected embryo. (B–D) Sample phenotypes of embryos injected w/20 ng TPMO.
Dorso-anterior defects are observed in approximately 25% of embryos, compared with approximately 7% of embryos injected with the 5-base mispair (165 embryos in
4 independent experiments). (E–J) in situ hybridization of not1 (E,H), otx2 (F,I), (G,J) in embryos injected with either the TPMO or the mispair (TPmis). In situ patterns shown
reﬂect embryos from Z3 biological replicates and are characteristic of at least 70% of embryos. For not1 expression, the pattern shown for TPMO embryos was observed in
30/37 embryos (81%); TPmis, 36/38 embryos (95%). For otx2 in gastrulae, the expression pattern shown for TPMO was observed in 19/24 embryos (79%); TPmis, 20/22
embryos (91%). For otx2 in late neurulae (2 biological replicates), the pattern in TPMO embryos appeared in 4/4 embryos, and the pattern in TPmis embryos appeared in 10/10
embryos.
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duction in miR-26 activity, higher concentrations of the inhibitor
yielded a substantial downregulation of multiple genes with sig-
niﬁcant developmental roles (genes: bmp4, smad1, vent1, vent2,
otx2, chordin, noggin,xnr3, bra, wnt11; data not shown), and thuschd    not   vn1  vn2   EF1  r18   Gmn
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Fig. 7. Overexpression of miR-26. (A) Embryos were injected with 2 ng/embryo of eith
goribonucleotides. Embryos were cultured until st. 10.5 and collected for RNA isolation an
EF1-a (EF1), rps18 (r18), and geminin (gmn). N ¼3 independent experiments. * Indicates s
expression in embryos injected with miR-26. N¼4 independent experiments; not1 exp
and 17/17 embryos injected with mtt 26.subsequent experiments were performed at 2 ng/embryo.
To evaluate effects of miR-26 knockdown on gene expression,
embryos were collected at st.10.25 for RNA isolation and Q-RT-PCR.
Unexpectedly, embryos injected with the miR-26 LNA showed
little quantitative change in expression of vent1, and a reduction inmtt-26   miR-26
er miR-26 or the mutated miR-26 (mtt 26); miRs were injected as duplexed oli-
d Q-RT-PCR. Genes tested included chordin (chd), not1 (not), vent1 (vn1), vent2 (vn2),
tatistical signiﬁcance (po0.05). (B) In situ hybridization showing expansion of not1
ression patterns are representative of 11/16 (69%) embryos overexpressing miR-26,
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Fig. 8. Reduction in function of miR-26. (A) Embryos were injected with a cocktail of PLS and Renilla luciferase plus 2 ng of either control LNA (ctrl LNA) or the miR-26 LNA
inhibitor; they were collected at st. 10.25–10.5 and lysed for luciferase assays. N¼8 experiments. In (A) and (B), * indicates statistical signiﬁcance (po0.05). (B) Embryos were
injected with 2 ng of either the miR-26 LNA oligonucleotide (LNA) or the control LNA and cultured until control embryos reached st. 10.5; they were then processed for RNA
isolation and Q-RT-PCR. Genes tested included vent2, gata4, chordin (chd), goosecoid (gsc), and nodal-related 3 (xnr3). N ¼3 independent experiments. (C–F) Embryos were
injected with oligonucleotides (C,D: 20 ng of either the TPMIS or the TPMO), (E,F: 2 ng of either the control LNA or the miR-26 LNA); ectodermwas isolated from the injected
embryos at st.10.25, and ectodermal explants were ﬁxed at st. 11.5 and hybridized in situ to show expression of sox2. Arrowheads indicate explants in which sox2 expression
is not detected. (C) explants of ectoderm containing TPMIS. (D) ectoderm injected with TPMO. (E) ectoderm injected with the control LNA; (F) ectoderm injected with miR-26
LNA. Explants are a representative sample of the total; each is oriented to show the maximum level of sox2 expression. (8G) Quantitative comparison of sox2 expression in
explants. Numbers in parentheses above the bar indicate the total number of explants. n Indicates statistical signiﬁcance (po0.05; Fisher's Exact Test). N¼4 independent
experiments.
C. Liu et al. / Developmental Biology 409 (2016) 26–38 35the expression of gata4. Expression of the organizer-speciﬁc genes
chordin and gsc was similar to that of control embryos, and only
the decrease in gata4 was statistically signiﬁcant. Largely similar
results were obtained using a MO directed against miR-26 (data
not shown).
These ﬁndings are in marked contrast to the effects of the
TPMO, presumably reﬂecting only a partial inhibition of miR-26 at
the LNA dosage used. To compare the effects of the partial miR-26
knockdown produced by miR-26 LNA with the TPMO, we in-
vestigated the effects of both treatments on the expression of sox2
in the midgastrula ectoderm. Sox2 is essential to the early neural
gene regulatory network (reviewed in Rogers et al. (2009)), and in
early gastrula ectoderm, it should be especially sensitive to the
amount of Smad1 activity. For this comparison, embryos were
injected with 20 ng of TPMO/TPMIS, or 2 ng of the miR-26 LNA or
the control LNA. Embryos were cultured until st. 10.25; the ecto-
derm was then isolated, and care was taken to exclude mesoderm.
Ectodermal explants were then cultured until st 11.5, ﬁxed, and
processed for in situ hybridization to visualize expression of sox2.The results are shown in Fig. 8C–G. Most of the ectodermal
explants containing the TPMIS showed regions of sox2 expression
(Fig. 8C), only 15% failed to express sox2. In contrast, sox2 ex-
pression was not detected in nearly half of the explants containing
the TPMO (Fig. 8D), indicating that an increase in Smad1 has re-
sulted in the loss of sox2, as expected. Parallel experiments using
the LNA26, however, yield a different result: here, there is no
signiﬁcant difference in the proportion of sox2-expressing explants
between explants injected with the control LNA (Fig. 8E) or the
miR-26 LNA (Fig. 8F). A quantitative comparison is shown in
Fig. 8G.
These ﬁndings indicate that at the concentrations used, the
TPMO is considerably more effective than the LNA at disrupting
the action of miR-26 on Smad1 activity. This is consistent with the
effects of these treatments on the PLS-luciferase activity, for which
the LNA produces a near-60% increase in luciferase activity, com-
pared with the TPMO, which produces a 2.5-fold increase (com-
pare Fig. 3B with 8A). Since higher concentrations of the LNA have
more global effects, we cannot increase the dosage of the LNA and
C. Liu et al. / Developmental Biology 409 (2016) 26–3836still obtain interpretable outcomes. One implication of this com-
parison is that, while the miR-26/Smad1 interaction may have
considerable signiﬁcance with regard to the regulation of Smad1
activity, this interaction is only a partial aspect of the overall
function of miR-26.4. Discussion
We have identiﬁed 180 miRNAs that are expressed in early
gastrulae; of these, 39 have not previously been reported for either
Xenopus species. Since miRbase 20 has only 21 miRNAs listed for X.
laevis, this represents a signiﬁcant increase in the number of
miRNAs identiﬁed for this species. We have also veriﬁed the pre-
dicted RNA stem-loop structure of genomic precursor sequences
for each of the new miRNAs and identiﬁed their genomic locations
in X. laevis genome assembly 7.1.
Our miRNA sequence analysis reveals expression of several
miRNAs that have been implicated in the establishment of distinct
germ layers during vertebrate embryogenesis. Members of both the
let-7 and miR-18 families have been implicated in mesoderm and
ectoderm development and the inhibition of endoderm via disrup-
tion of nodal signaling in mammalian and amphibian embryos
(Colas et al., 2012). A similar endoderm-inhibiting role for miR-92
has emerged from studies of endoderm formation in zebraﬁsh (Li
et al., 2011). Moreover, miR-427, the most abundantly expressed
miRNA in our analysis, is required for the establishment of dorsal
mesoderm in Xenopus; miR-427 and its mammalian orthologue
miR-302 have been shown to inhibit nodal signaling, and thus the
establishment of the endodermal lineage (Rosa et al., 2009).
4.1. Small RNAs in Xenopus development
Xenopus oocytes and embryos contain a heterogeneous popu-
lation of small RNAs (deﬁned as 35 bases or smaller); our results
and those of others suggest that miRNAs comprise only a minor
fraction of this pool. Other RNA sequencing studies have shown
that piRNAs are strongly represented in oocytes (Armisen et al.,
2009) and gastrulae (Faunes et al., 2012). In addition, novel classes
of small RNAs have been identiﬁed: RNAs representing stable in-
tronic sequences (sisRNAs) are present in oocytes and persist
through pre-MBT stages (Gardner et al., 2012), while small intronic
transposable element (site) RNAs are detected at blastula and later
stages (Harding et al., 2014). The siteRNAs are distinct from sisR-
NAs and represent the majority of sequences identiﬁed in the
study. Although the genomic locations of siteRNAs and their cor-
respondence with repressive chromatin modiﬁcations may im-
plicate siteRNAs in transcriptional repression, the roles and func-
tional signiﬁcance of these novel classes of small RNAs are poorly
understood. For some small RNAs, including some miRNAs and
piRNAs, expression in embryos may reﬂect persistence following
activity during oogenesis, rather than distinct roles in embryonic
development.
Although most of these studies identify small RNAs in X. tro-
picalis, the comparison of our ﬁndings with those of Faunes et al.
(2012) indicate that the miRNA populations expressed at the
gastrula stage in both species are similar. Moreover, the results of
Faunes et al. (2012) reﬂect similar considerations regarding re-
producibility, in terms of the individual miRNAs expressed. We
attribute the limited reproducibility of our miRNA sequencing to
two causes. First, the very high proportion of non-miRNA se-
quences in the selected size class means that the representation of
miRNAs is likely to be well below the level of saturation, at which
representation in a sequenced pool should reﬂect relative abun-
dance of the miRNA in vivo. Sequencing at these subthreshold
levels will distinguish between miRNAs expressed at higher orlower abundance but will not yield true quantitative relationships.
Second, apparent relative expression levels for miRNAs can be
skewed by “library bias”, in which differences in the afﬁnity of
speciﬁc library adapter sequences for individual 5’ bases lead to a
false differential representation of some miRNAs relative to others
(Sun et al., 2011; reviewed in van Dijk et al. (2014)). This bias factor
is likely to account for some of the variation in relative abundance
between libraries prepared with different adapters. Nonetheless,
the extensive overlap between our sequencing results and those of
Faunes et al. (2012) suggest that most of the miRNAs expressed
above very low levels are represented in our results.
4.2. miR-26 and Smad1 function in development
The TPMO experiments demonstrate a role for miR-26 in the
regulation of Smad1 and the BMP/Smad1 network. In isolation, the
TPMO studies demonstrate only that Smad1 is under translational
control mediated via the corresponding site on the 3′UTR. The loss
of translational control via mutations in the seed-binding se-
quence (PLS-MUT), and its restoration via compensatory muta-
tions in the seed sequence of miR-26 (mtt-26) conﬁrm that this
translational inhibition is mediated by miR-26. Here, as in previous
studies (Choi et al., 2007), the TPMO allows the disruption of a
single miR-target mRNA interaction without affecting other miR
targets. Embryos injected with the TPMO show quantitative and
spatial alterations in expression of genes involved in dorsal–ven-
tral pattern and neural speciﬁcation, demonstrating that transla-
tional inhibition of Smad1 by miR-26 is required for normal pat-
terning and tissue speciﬁcation during gastrulation.
These conclusions derive modest support from miR-26 over-
expression studies. Reduction-of-function studies of miR-26 reveal
a more complex picture, however, indicating that miR-26 has ad-
ditional essential functions that are independent of the effects on
BMP/Smad1 signals. These other functions presumably include
some of the other predicted targets of miR-26, or other targets that
have not been identiﬁed. The lower concentrations of LNA26 used
in our experiments are insufﬁcient to produce a substantial in-
crease in Smad1 activity, while higher concentrations yield chan-
ges in gene expression that presumably reﬂect the pleiotropic
action of miR-26 as a regulator of multiple genes.
4.3. Regulation of Smad1 protein
Translational control by miR-26 is only one of several reg-
ulatory mechanisms that govern the accumulation of smad1 pro-
tein. Smad1 is a substrate for erk MAPK phosphorylation
(Kretzschmar et al., 1997), and inhibitory phosphorylation by erk
MAPK is a major component of post-translational regulation of
smad1 activity in early development (Sater et al., 2003, Pera et al.,
2003). Phosphorylation by erk MAPK is a priming step for sub-
sequent GSK3 phosphorylation, which generates a binding site for
the HECT-Domain ubiquitin ligase smurf1, which mediates Smad1
ubiquitination and inhibits Smad1 nuclear translocation (Sapkota
et al., 2007). In mammalian cells, initial phosphorylation of smad1
by CDK 8/9 facilitates Smad1 activity by creating a binding site for
the transcription factor Yap1; transcriptional activity is followed
by GSK3 phosphorylation, leading to binding of Smurf1 (Aragón
et al., 2011). Thus, Smad1 protein levels are controlled in part via
ubiquitin-mediated proteolysis. These post-translational control
mechanisms may limit the effectiveness of miR-26 in regulating
Smad1 accumulation.
4.4. MicroRNA-dependent regulation of TGF-β family signaling
MicroRNAs play functionally signiﬁcant roles in the regulation
of several TGF-b pathways critical for early development. The
C. Liu et al. / Developmental Biology 409 (2016) 26–38 37activin receptor Acvr2A is under the control of miRs-15 and 16, and
disruption of these interactions leads to expansion of the Orga-
nizer (Martello et al., 2007). Fine-tuning of nodal signaling is ac-
complished via miRNA-dependent regulation of both nodal and its
antagonist lefty. Nodal signaling is additionally downregulated by
miRNA targeting of Acvr1b (let-7) and smad2 (miR-18), and these
interactions are critical for the establishment of mesoderm and
ectoderm in mammalian and amphibian embryos (Colas et al.,
2012). Our results demonstrate that the BMP4/Smad1 pathway is
also under miRNA-dependent regulation during early develop-
ment, and that these regulatory interactions contribute to the
establishment of mesodermal pattern during gastrulation.
The miR-26a binding site in the smad1 3′UTR is highly con-
served across vertebrate genomes (see Targetscan.org; Lewis et al.,
2005; Friedman et al., 2009), and miR-26 plays a functionally
signiﬁcant role in the regulation of smad1 across several distinct
processes of mesodermal differentiation. Regulation of the smad1
transcript by miR-26 has been shown to modulate smad1 activity
during osteogenic differentiation of human adipose tissue-derived
stem cells (Luzi et al., 2008). Subsequent studies have shown that
the modulation of smad1 by miR-26 is required for both mam-
malian skeletal muscle differentiation and muscle regeneration
following injury (Dey et al., 2012); this interaction is also required
for osteogenic differentiation of unrestricted somatic stem cells
from human cord blood (Trompeter et al., 2013). In some instances
in which smad1 acts as a positive regulator of differentiation, miR-
26 functions to delay or inhibit differentiation, as during angio-
genesis (Icli et al., 2013), or in phenotypic switching of vascular
smooth muscle cells (Leeper et al., 2011).
4.5. Signiﬁcance of biochemical identiﬁcation of miRNA targets
Our ﬁndings demonstrate the feasibility of a biochemical ap-
proach to the identiﬁcation of miRNA target transcripts as a pre-
lude to the analysis of functionally signiﬁcant miRNA-mRNA target
interactions in embryos. Argonaute co-immunoprecipitation, used
in a variety of tissues and cell lines (e.g., Chi et al., 2009; Boudreau
et al., 2014), is easily adapted for use in Xenopus tissues. Moreover,
this approach takes advantage of key strengths of the Xenopus
experimental system and its suitability for biochemical investiga-
tion. This approach should expand and strengthen the analysis of
translational control and its roles in vertebrate development.Author contributions
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